Syngene International Q3 Results: Net profit dives 89% on large-molecule biologics impact

Syngene International reported a net profit of ₹15 crore for Q3 FY26, down 88.5% YoY from ₹131 crore. Revenue declined 2.8% to ₹917 crore, while EBITDA fell 25.9% to ₹209.2 crore, leading to a margin contraction to 22.8% from 30% YoY.

Leave a Reply

Your email address will not be published. Required fields are marked *